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Transforming growth factor ,B1 secreted from scirrhous gastric cancer
cells is associated with excess collagen deposition in the tissue
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Summary To explore the mechanism of increased collagen deposition in scirrhous carcinoma of the stomach,
an attempt was made to define the role of transforming growth factor P1 (TGF-PI), secreted from tumour
cells, as a possible humoral factor which functions in a paracrine manner to stimulate the production of
collagen in regional fibroblasts. Immunohistochemical staining revealed that tumour cells in scirrhous car-
cinomas were generally stained more intensively than those in other types of carcinomas. On Northern blot
analysis the tumour cells established from scirrhous carcinoma (KATO-III, OCUM-1 and HSC-39) exhibited
relatively strong signals compared with those from non-scirrhous carcinoma (MKN-28 and MKN-45). In the
culture media of scirrhous carcinoma cells, the active form of TGF-PI was detected, while in those of the
non-scirrhous carcinoma cells the latent form was demonstrated by both colony and radioreceptor assays. The
culture medium from KATO-III showed strong stimulating activity of collagen synthesis in fibroblasts, and
this activity was partially neutralised by an anti-TGF-PI antibody. These results suggest that tumour cells in
scirrhous carcinoma produce more active-form TGF-1I than does non-scirrhous carcinoma and thus is
partially responsible for the observed enhanced collagen deposition in the region.
Scirrhous cancer of the stomach is characterised by pro-
nounced proliferation of the interstitium, that is deposition
of an excessive number ofcollagen fibres. The mechanisms of
interstitial proliferation in scirrhous gastric cancer still re-
main obscure in many respects. In a previous immunohisto-
logical study we showed that scirrhous gastric cancer cells
themselves produce collagen in large amounts (Niitsu et al.,
1988a). That finding does not necessarily preclude the pos-
sibility that, while producing collagen themselves, scirrhous
gastric cancer cells release some humoral factors that stimu-
late fibroblasts in the interstitial space to synthesise collagen,
and thus promote fibrosis.
Transforming growth factor P1 (TGF-P1) is one of the
most potent cytokines for promoting collagen synthesis by
fibroblasts (Ignotz & Massague, 1986; Terui et al., 1990).
Yoshida et al. (1989) demonstrated that TGF-41 mRNA is
highly expressed in tumour cells of scirrhous gastric cancer.
Hirayama et al. (1992), using immunohistochemical methods,
also pointed out the increased expression of TGF-P1 in
penetrating tumour cells of early gastric cancer. On the other
hand, Mizoi et al. (1993) claimed, on the basis of immuno-
electron microscopy, that cancer stroma is promoted by
TGF-P1 mainly secreted from stroma cells. Thus, the origin
of TGF-,13, which induces interstitial proliferation, is still
controversial. Furthermore, the pronounced collagen deposi-
tion cannot be explained simply by increased expression of
TGF-P1 in the cells since TGF-P1 is generally secreted as a
latent or precursor molecule, which may be a possibility in
this particular gastric cancer.
The TGF-13I molecule is rarely secreted as an active form
but it may readily be converted into this state soon after it is
secreted. In the present investigation, the expression of TGF-
P1 in scirrhous gastric carcinoma tissues was examined by an
immunohistochemical method. The secreted form of the
TGF-P1 molecule in the culture media was investigated using
scirrhous gastric cancer cell lines by assays for receptor-
binding activity, colony-forming activity and collagen synthe-
sis-stimulating activity.
Materials and methods
Tissue specimensfrom gastric carcinoma and histological
classification
Tissue specimens were obtained by surgical resection from 20
patients with gastric cancer of various histological types:
seven had scirrhous gastric carcinomas (five with poorly
differentiated adenocarcinoma and two with signet-ring cell
carcinoma) and 13 patients had non-scirrhous gastric car-
cinoma (three with poorly differentiated adenocarcinoma,
three with well-differentiated tubular adenocarcinoma, five
with moderately differentiated tubular adenocarcinoma and
two with papillary adenocarcinoma). Gastric carcinoma was
classified morphologically into types I-IV (type I, non-
ulcerated polypoid lesion growing into the lumen of the
stomach; type II, an ulcerated, circumscribed disc-like tum-
our with clearly defined, sharp margins; type III, an ulcerated
tumour that is not sharply circumscribed; type IV, diffuse,
infiltrating type of gastric cancer that can involve the entire
stomach) according to Borrmann's classification (Borrmann,
1926). The histopathological diagnosis was made by N. Sato,
First Department of Pathology, Sapporo Medical University,
in blinded fashion and the degree of fibrosis was classified
into three grades (intermediate, medullary and scirrhous
type) according to the classification of the Japanese Research
Society for Gastric Cancer (Nagayo et al., 1985).
Established cell linesfrom gastric carcinoma
KATO-III (Sekiguchi et al., 1978), derived from a scirrhous
gastric carcinoma, was a gift from Dainippon Laboratory
Co. (Osaka, Japan). OCUM-1 (Kubo, 1991), established
from a scirrhous gastric carcinoma, was kindly provided by
T. Kubo, First Department of Surgery, University of Osaka
City (Osaka, Japan). HSC-39 (Yanagihara et al., 1991),
derived from a scirrhous gastric carcinoma, was kindly pro-
vided by K. Yanagihara, Department of Pathology, Research
Institute for Nuclear Medicine, Hiroshima University
(Hiroshima, Japan). MKN-28 and MKN-45 derived from a
non-scirrhous gastric carcinoma were kindly provided by
Midori-Juji Co. (Osaka, Japan). HEL derived from human
embryonic lung fibroblasts was kindly provided by Asahi
Chemical Industry (Tokyo, Japan). NRK-49F was provided
by the Institute of Physical and Chemical Research (Saitama,
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Japan). All cell lines were maintained with Dulbecco's modi-
fied Eagle medium (DMEM) or RPMI-1640 medium (Gibco,
Grand Island, NY, USA) supplemented with 10% fetal calf
serum (Flow Laboratories, North Ride, Australia), 100 U
ml-' penicillin G, 2mM L-glutamine and 100l gml1' of
kanamycin sulphate in tissue culture flasks (Falcon no. 3024,
Becton Dickinson, San Jose, CA, USA) at 37°C under 5%
C02-air.
Extraction ofTGF-PIfrom bloodplatelets
For extraction of TGF-P1 from blood platelets, the method
described by Assoian et al. (1983) was employed. Centrifuga-
tion of 50 units of an enriched platelet suspension yielded
25 g of platelets. From this platelet preparation, the soluble
fraction was obtained in the acid-ethanol solution (93%
ethanol, 0.23 M hydrochloride acid) and ethanol-diethyl eth-
er (1:2) was added to obtain a precipitate. TGF-P1 was
chromatographically purified with a Bio-Gel P60 column
equilibrated in 1 M acetic acid and subsequently in a Bio-Gel
P60 column equilibrated in 1 M acetic acid-8 M urea. A
single band was obtained under reducing condition which
had a molecular weight of 12,500 daltons as estimated by
sodium dodecyl sulphate-polyacrylamide gel electrophoresis
(SDS-PAGE).
Anti-TGF-PI polypeptide antibodies
Two types of polyclonal antibodies to two synthetic peptides
(NI-15 and N92-103) were raised in rabbits: these corres-
ponded to the postulated antigenic determinants of TGF-P1
polypeptide as described by Terui et al. (1990). IgG fractions
were prepared from these antisera by passage through pro-
tein A-Sepharose. Both the anti-NI-15 and anti-N92-103
antibody were useful for immunohistochemical staining,
while only the latter showed neutralising activity (data not
shown). Therefore, in the present experiments, the anti-NI-15
antibody was used for immunohistochemical staining and the
anti-N92-103 antibody was used for neutralisation.
Immunohistochemical stainingfor TGF-P1 in gastric cancer
tissues
Immunohistochemical staining for TGF-131 followed the me-
thod of Heine et al. (1987). Gastric cancer tissues were fixed
in Bouin's solution [0.9% picric acid, 9% (v.v) formaldehyde,
5% acetic acid]. After dehydration through a graded series of
ethanol solutions, the gastric cancer tissues were embedded in
paraffin. Sections 5 Lm thick were deparaffinised and sub-
jected to immunohistochemical staining according to the fol-
lowing protocol: (a) blocking of endogenous peroxidase with
0.3% hydrogen peroxide in methanol (30 min); (b) blocking
of non-specific protein binding with 10% goat serum (45
min); (c) incubation with 40 fLg ml-' anti-TGF-P1 (N1-15)
(2 h); (d) staining with the avidin-biotin-conjugated perox-
idase method (ABC-kit; Vector Laboratories, Burlingame,
CA, USA); (e) treatment with 0.5 mg ml-' diaminobenzidine
tetrahydrochloride (Sigma, St Louis, MO, USA) in 0.05 M
Tris-buffered saline (0.05M Tris-HCl, pH7.2, 0.15M sod-
ium chloride) containing 0.1% hydrogen peroxide (5min).
Controls were prepared by replacing the anti-TGF-P1 rabbit
IgG by normal rabbit IgG.
Northern blot hybridisation
The total RNA fraction was extracted from the cells by acid
guanidinium thiocyanate-phenol-chloroform according to
the method of Chomczynski and Sacchi (1987). The cells
(2 x 108) and RNAzol (Cinna/Biotecx Laboratories Interna-
tional) were homogenised and a one-tenth volume of chloro-
form added. The suspension was shaken vigorously for 10 s,
cooled on ice for 15 min and centrifuged at 10,000 g for
20min at 4°C. After centrifugation, the aqueous phase was
transferred to a fresh tube, mixed with an equal volume of
isopropanol and placed at - 20°C for 1 h to precipitate
RNA. The RNA was then rinsed with 75% ethanol. After
the total RNA was denatured with formamide and for-
maldehyde, it was electrophoresed by the method of Gold-
berg (1980) on horizontal 1.0% agarose gel (7.5 x 6.5 cm,
Bio-Rad, Richmond, CA, USA) at 1OOV for 40min. With
use of a transblot electrophoresis apparatus (Transblot Ap-
paratus, Bio-Rad), the RNA was transferred from agarose to
a nylon filter (Zeta-Probe blotting membrane, Bio-Rad). The
EcoRI-PstI restriction fragment (1572 bp) from the KB cell
TGF-P1 cDNA clone (Urushizaki et al., 1987) was labelled
with [a-32P]dCTP by random hexamer priming (Feinberg &
Vogelstein, 1984) and was used as probe. The filter was then
submerged in a hybridisation buffer [40% formamide, 4 x
SSC, 50mM N-(2-hydroxyethyl)piperazine-N'-2-ethanesulph-
onic acid (HEPES) buffer, 10 x Denhardt's solution, 100lag
ml-I denatured salmon sperm DNA, pH 7.4] to which 32p_
labelled cDNA probe had been added, and incubated at 42°C
for 18 h. After hybridisation, the filter was washed and
autoradiographed.
Preparation ofconditioned culture medium
Gastric carcinoma cells were suspended in the RPMI-1640
medium (Gibco, Grand Island, NY, USA) at a density of
1 x 107 cells ml-'. After incubation for 2 h at 37°C in 5%
carbon dioxide, the medium was centrifuged and the super-
natant was collected for use as the culture medium (Nitsu et
al., 1988b). To activate latent TGF-,11 the culture medium
was acidified by the addition of hydrochloric acid to a final
concentration of 115 mM and subsequent incubation for 2 h
at 4°C as described by O'Connor-McCourt and Wakefield
(1987). The culture medium was then neutralised by addition
of a 1/40 volume of 1 M sodium HEPES, pH 7.0 and sodium
hydroxide to a final concentration of 115 mM.
Preparation ofKATO-III cell lysate
KATO-III cells (1 x 107) were mixed with 1 ml ofphosphate-
buffered saline and the suspension was immediately homog-
enised in a Dounce homogeniser (50 strokes). Then the
homogenate was centrifuged (100,000g at 4°C for 30 min) to
obtain its supernatant as a cell lysate.
Soft agar assayfor TGF-PI activity
The cultivation of normal rat kidney cells (NRK-49F) on a
soft-agar medium followed the method of Roberts et al.
(1980). To the 35 mm well of a six-well culture plate (Falcon
no. 3046), a basal layer of 1.0 ml DMEM in which 10% FCS
had been mixed with 0.5% agar was added and hardened. To
the layer above this basal layer, 9 x 103 NKR-49F cells in
1.0 ml of DMEM containing 0.3% agar, 2.5 ng ml-' epider-
mal growth factor (Nakarai, Tokyo, Japan) and 1 ngml'
TGF-P1I or 0.1 ml of culture medium or the cell lysate of
KATO-III was added and hardened. Culture was continued
for 7 days at 37°C under 5% carbon dioxide-air, and the
colony number per well was measured.
Radioreceptor assay
The radioreceptor assay for TGF-13I was carried out by the
method of Frolik et al. (1984). ['251I]TGF-P1 (specific activity
588 Cimmol-') was purchased from Amersham Japan (Tokyo,
Japan). NRK-49F cells were plated in 24-well culture plates
(2.0cm2 per well, Becton-Dickinson) at a density of 1 x lIO
cells per well. The cells were washed with binding buffer
(DMEM pH 7.4 containing 0.1% bovine serum albumin and
25 mM HEPES), and then 1 ml of binding buffer containing
0.25 ngml-' ['25I]TGF-P1I and 0.1 ml of samples was added
to each well. Non-specific binding of ['251]TGF-P1 was deter-
mined in the presence of 1 fig of 50% pure unlabelled TGF-
P1. The incubation was continued for 2 h at 4°C on a rocker
platform. The ['25I]TGF-13l-bound cells were then washed
three times with binding buffer and removed from the plate
by treatment with 1 ml of solubilisation buffer (1% TritonTGF-P1 AND COLLAGEN DEPOSITION IN SCIRRHOUS CANCER 779
X-100, 10% glycerol, 20 mM HEPES, pH 7.4). Radioactivity
of these cells was measured in a gamma-counter. A standard
competition curve was constructed with 0.1-1OOngml-'
purified TGF-P31.
Assayfor collagen synthesis by humanfibroblasts (HELs)
We used the method of Postlethwaite et al. (1984) to measure
the ability of HEL cells to synthesise collagen. HEL cells
a
(1 x 105 mlP- per well, 24-well culture plate) were added with
10% KATO-III culture medium containing 250jig ml-' nor-
mal rabbit IgG or 250 gml-' anti-TGF-P1 (N92-103) IgG,
and 5ftCi ml-' of [3H]proline. After 24 h, protein secreted in
the supernatant was precipitated in trichloroacetic acid
(TCA), and the amount of [3H]proline incorporated in this
protein fraction was determined to give a measure of total
protein synthesis. In another experiment the protein in the
supernatant was first degraded with bacterial collagenase,
La
b f
c 9
d h
Figure 1 Immunohistochemical staining of TGF-PJI in gastric carcinomas of various histological types. The cytoplasm of the
tumour cells was strongly stained in specimens of scirrhous type (a, b, c and d), while in specimens of non-scirrhous type (e, f and
g) relatively weak staining was observed. The normal portion of the surgically removed specimen of gastric carcinoma was negative
for staining (h) ( x 170).780 K. MAHARA et al.
and collagenase-insensitive protein was precipitated with
TCA, and the amount of [3H]proline incorporated in this
precipitate was measured. The amount of [3H]proline incor-
porated in the collagenase-sensitive fraction was calculated as
the amount of [3H]proline incorporated in the total protein
fraction minus the amount of [3H]proline incorporated in the
collagenase-insensitive fraction. The amount of collagen syn-
thesis relative to total protein synthesis (hereafter designated
as the collagen synthesis rate) was calculated by the following
equation taken from Peterkofsky and Diegelmann (1971):
Collagen synthesis rate (%) =
Collagen-sensitive fraction x 100
5.4 x collagenase-insensitive fraction
+collagenase-sensitive fraction
Results
Immunohistochemical analysis ofTGF-PI expression in gastric
cancer tissues
Figure 1 shows eight specimens of typical gastric cancer
tissues with various histological types stained for TGF-p1. In
all four specimens of scirrhous gastric cancer, tumour cells
(Figures la-d), infiltrating sparsely or forming islets in the
interstitial tissue, stained intensely. In the specimens of non-
scirrhous cancers (Figure le-g), on the other hand, the
carcinoma cells stained unevenly and much less intensely
than did the scirrhous gastric cancer cells. When staining was
as strong as in the scirrhous gastric cancer cells in Figure
la-d, the grade was defined as (+ +). Similarly, when stain-
ing was moderate, as in Figure le and f (Borrmann type II
gastric cancer), it was graded as (+). Weak staining as in
Figure Ig (Borrmann type III gastric cancer) was graded as
(± ). Failure to stain, as in normal pyloric glands, shown in
Figure lh, was graded as (-). On the basis of such immuno-
histological observation, the staining intensity of 20 cases of
gastric cancer was analysed as shown in Table I. Of the seven
scirrhous gastric cancer (Borrmann type IV) tumours
(nos. 14-20), one (no. 16) stained moderately (+) and the
remaining six stained intensely for TGF-P1 (+ +). In the
cases of Borrmann types II and III, non-scirrhous gastric
cancers, cancer tissue specimens stained relatively weakly
compared with scirrhous cancers. There was a good relation-
ship between the degree of fibrosis and the intensity of
staining.
TGF-PI mRNA expression in various gastric cancer cells
The expression ofTGF-Pi1 mRNA in three different scirrhous
gastric cancer cell lines (KATO-III, OCUM-1 and HSC-39)
and two different non-scirrhous gastric cancer cell lines
(MKN-28 and MKN-45) was investigated by Northern blot
analysis. As shown in Figure 2, a band corresponding to
TGF-P1 mRNA was observed at 2.5 kb in all the cell lines.
The expression ofTGF-P1 mRNA signal relative to that of a
P-actin signal was 5.8 for KATO-III, 1.6 for OCUM-1, 2.6
for HSC-39, 1.0 for MKN-28 and 0.7 for MKN-45. From
these data it is obvious that there was a tendency for the
formation of TGF-P1 mRNA to be more marked in scirr-
hous gastric cancer cells (the first three cases) than in non-
scirrhous cancer cells (the last two cases).
TGF-PJ activity in the culture media ofvarious gastric cancer
cells
The concentration ofTGF-P1 in the culture media of various
gastric cancer cell lines was measured by radioreceptor as-
says, using NRK-49F as a target cell. The results of the
measurements are shown in Figure 3a. Without acid treat-
ment, the concentrations of TGF-P1 in the culture media of
scirrhous gastric cancer cells were 2.98 ngml' for KATO-
III, 1.72 ngml-' for OCUM-1, and 1.63 ngml-' for HSC-39,
while those of non-scirrhous gastric cancer cells (MKN-28
and MKN-45) were below the detection limit. When the
measurements were carried out after acid treatment, no
change in the concentrations of TGF-,1I was observed for
scirrhous cancer cells, but TGF-P1 became detectable in the
acid-treated culture media of non-scirrhous gastric cancer
cells in concentrations of 1.12ngml-' for MKN-28 and
1.54 ngml-' for MKN-45. In order to determine the intracel-
lular form of TGF-p1, a similar measurement was made on
cell lysate from KATO-III. Without acid treatment, the
TGF-P1 concentration was below the detection limit, indica-
ting that intracellular TGF-P1 occurs in a latent form while,
after acid treatment, it was converted to an active form in a
concentration of 2.61 ng ml1'.
Table I Comparison of the intensity of immunohistochemical staining for TGF-p1 in
20 gastric carcinomas of various histological types
Case Borrmann Histological Grade of Relative amount
no. classification diagnosis' immunoreactivityb offibrous septa
1 II Tub 2 + Intermediate
2 II Tub 2 + Intermediate
3 II Por + Intermediate
4 II Tub 1 _ Intermediate
5 II Tub 1 + Intermediate
6 III Tub 2 + Intermediate
7 III Tub 2 + + Intermediate
8 III Tub I + Intermediate
9 III Pap + Medullary
10 III Por + Intermediate
11 III Pap + Medullary
12 III Por + Intermediate
13 III Tub 2 + Intermediate
14 IV Por + + Scirrhous
15 IV Sig + + Scirrhous
16 IV Por + Scirrhous
17 IV Por + + Scirrhous
18 IV Por + + Scirrhous
19 IV Sig + + Scirrhous
20 IV Por + + Scirrhous
aTub 1, well-differentiated tubular adenocarcinoma; tub 2, moderately differentiated
tubular adenocarcinoma; por, poorly differentiated tubular adenocarcinoma; pap,
papillary adenocarcinoma; sig, signet-ring cell carcinoma. bGrade of immunoreactivity
was defined from intensity of staining in Figure 1 as described in the text.TGF-i1 AND COLLAGEN DEPOSITION IN SCIRRHOUS CANCER 781
Colony assays for TGF-13 activity are also carried out to
confirm the above observation (Figure 3b). The culture
media from scirrhous gastric cancer cells showed apparent
colony formation regardless of acid treatment, while colony
formation was observed in the culture media of non-scirr-
1 2 3 4 5
2.5 kb
(TuF-o11)
hous gastric cancer cells only after acid treatment. The cell
lysate of KATO-III did not stimulate colony formation
unless it was treated with acid.
Effects ofKATO-III culture medium on collagen synthesis by
fibroblasts (HELs)
Collagen synthesis by HEL cells showed an about 6.3-fold
increase with the addition of KATO-III cell culture medium
(10%), compared with the level of collagen synthesis without
the addition of the same culture medium, and the rate of
synthesis of collagen was also increased from 6.3% to 34.2%.
Furthermore, when the anti-N92-103 antibody with neutralis-
ing activity for TGF-P1 was added to the culture medium at
a concentration of 250 lg ml , the increase in collagen syn-
thesis was inhibited by approximately 42% (Figure 4).
Discussion
In an attempt to clarify the mechanism of the increase in
collagen deposition in the stroma of scirrhous gastric car-
cinoma, the present investigation examined the expression of
TGF-P1 in scirrhous gastric carcinoma tissue and the activity
of TGF-,B in cell lines obtained from tissue.
On immunohistochemical analysis, scirrhous gastric cancer
cells stained for TGF-,1I more intensely than did non-
scirrhous gastric cancer cells, and there was a linear relation-
13-Actin - _
Figure 2 Northern blot analysis of TGF-PI mRNA from five
established gastric carcinoma cell lines. Eight micrograms of total
RNA was separated on 1.0% agarose gel, transferred onto nylon
filter and hybridised with 32P-labeled TGF-p1 cDNA probe. A
,-actin probe was employed as internal standard. Lane 1, KATO-
III; lane 2, OCUM-1; lane 3, HSC-39; lane 4, MKN-28; lane 5,
MKN-45.
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Figure 3 TGF-P1 activity in the culture media from five estab-
lished gastric carcinoma cell lines. The activities were estimated
by radioreceptor assay (a) and colony assay (b) as described in
Materials and methods. In both figures, the open and hatched
histograms represent the latent and active forms of TGF-PJ
respectively.
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Figure 4 Effect of culture medium from KATO-III cells on the
collagen synthesis of HEL cells. Collagen synthesis of HEL cells
treated with 10% culture medium of KATO-III was measured as
described in Materials and methods then 250jugmlP anti-N92-
103 antibody, which has neutralising activity for TGF-pl, was
added to this culture medium to verify the effect of TGF-P1 on
collagen synthesis. As a control, normal rabbit IgG was used.
Bars indicate mean ± s.d. *P<0.01.782 K. MAHARA et al.
ship between staining ofTGF-PI and the degree offibrosis in
stroma. Furthermore, scirrhous gastric cancer cell lines (KA-
TO-III, OCUM-1 and HSC-39) had a more intense signal of
TGF-PI mRNA than non-scirrhous gastric cancer cell lines
(MKN-28 and MKN-45). Those findings are compatible with
the report by Yoshida et al. (1989), who found increased
expression ofTGF-P1 mRNA in scirrhous cancer tissues, and
that by Hirayama et al. (1992), who found intense staining of
TGF-P1 in penetrating cells of the linitis plastica type of
gastric cancer: they are also consistent with the notion that
cancer cells produce TGF-f31 to promote interstitial prolifera-
tion around them. On the other hand, Mizoi et al. (1993)
recently claimed that despite the fact that both tumour cells
and stromal cells were stained positively, fibrosis in gastro-
intestinal cancer is promoted by TGF-p1, mainly secreted
from stromal cells, which was thought to be the case because
latent TGF-,l-binding protein (LTBP), which is supposed to
facilitate the secretion of TGF-p1, was identified only in
stromal cells.
However, lack of LTBP expression in tumour cell does not
necessarily mean that tumour cells are unable to secrete
TGF-p1, since cells with no LTBP are also known to secrete
TGF-P1 albeit slowly (Miyazono et al., 1991). An even more
important observation was that scirrhous cell lines secreted
mainly active TGF-p1, while non-scirrhous cells secreted
latent TGF-pl. In fact the present studies on established cell
lines clearly demonstrated that TGF-PI was indeed secreted
in the culture medium in an appreciable amount. This finding
led us to the postulate that the difference in the amount of
interstitial connective tissue in scirrhous and non-scirrhous
gastric cancers depends not only on the difference in the
amount of TGF-,B produced and released but also on
whether or not TGF-Pl is activated.
The next subject of interest was the mechanism by which
active TGF-PI is released. This was investigated in scirrhous
gastric cancer KATO-III cells, which showed the highest
TGF-P1 activity of all tested cancer cell lines. Because TGF-
PI in the cell lysate was inactive, it is presumed that TGF-PI
is activated after release from the cancer cell. Subsequent
unpublished studies by us showed that scirrhous gastric
cancer KATO-III cells secrete a proteinase that converts
TGF-P1 from an inactive to an active form.
A confirmative investigation was then carried out to deter-
mine whether or not the culture medium of KATO-III cells
promotes collagen synthesis by fibroblasts. The results ob-
tained using the neutralising antibody clearly indicated that
TGF-P1 is one of the factors stimulating collagen synthesis in
the culture medium.
Lastly, one may consider the possibility that active TGF-
P1 inhibits the proliferation of tumour cells by an autocrine
action. Yanagihara and Tsumuraya (1992), in fact, reported
that HSC39 cells underwent apoptosis in the presence of
active TGF-p1. However, their experiment was performed
under exceptional conditions; they selected particular clones
grown in serum-starved medium. The tumour cells, including
HSC39, examined in the present investigations are all estab-
lished cell lines and therefore apparently are able to pro-
liferate regardless of the fact that some of them produce
active TGF-pl. In addition, it is well known that tumour
cells quite often escape from growth suppression by TGF-pl.
The mechanisms of that escape are presently under investiga-
tion.
In conclusion, the interstitium in scirrhous gastric cancer
seems to proliferate by a mechanism whereby TGF-P1 secre-
ted from the gastric cancer cells stimulates collagen synthesis
by fibroblasts around them.
We previously reported that myelofibrosis in megakaryo-
blastic leukaemia is attributable to the action of active TGF-
PI (Terui et al., 1990). Further studies need to be carried out
to conclude that active TGF-P1 is required to produce the
vigorous fibrosis common to many malignant tumours.
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